Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery.
about
Gene-based therapy for hypertension--do preclinical data suggest a promising future?Similar effects on rat renal mesangial cells by expressing different fragments of adrenomedullin gene in vitro.Ontogenetic aspects of hypertension development: analysis in the rat.A critical look at cardiovascular translational research.Gene therapy of hypertensive vascular injury.The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.Gene therapy for hypertension: sense and antisense strategies.Genetic targeting of the renin-angiotensin system for long-term control of hypertension.Potential renovascular hypertension, space missions, and the role of magnesium.Development and use of gene transfer for treatment of cardiovascular disease.Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon.Endothelial cell dysfunction: can't live with it, how to live without it.Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.Viral vectors for vascular gene therapyUremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function.Construction of a recombinant adenovirus carrying endothelial nitric oxide synthase gene and its expression and control in esophageal smooth muscle cells.Circadian renal rhythms influenced by implanted encapsulated hANP-producing cells in Goldblatt hypertensive rats.Gene therapy for hypertension and restenosis.Human eNOS gene delivery attenuates cold-induced elevation of blood pressure in rats.NO Signaling in the Cardiovascular System and Exercise.
P2860
Q31060643-C6740008-5A8C-4EB0-9C80-937EF2580358Q33217270-D4F49A7E-D20A-4CE4-8B0E-488B0920E105Q33744642-038DA105-04F0-4895-A02C-AD6E83CEBD0CQ33774783-FCBF1859-E1CF-49DF-AE19-B8716AA31906Q34028434-33DA5949-7638-46D2-BF91-F034D3CCBF16Q34060215-7327C13A-7F9B-4E4E-A4F2-B02C3B657EBAQ34451899-A5D06FFF-F69F-4E51-8B5B-4B0C8EE1C29AQ34492788-413766DF-D099-4594-8905-132EC708F8EFQ35026662-085A9059-5FE5-4EF2-B10B-A6049B83EE3AQ35087832-3B069106-DD0A-48E9-BAFA-974070D43193Q35952223-851574C0-BFBC-4C53-A721-BE93DA718AE0Q36093993-9FCAC539-47D6-4D72-8931-6160A942E79BQ37388154-F5AE27D8-59BF-4910-AD65-0ABD13DB0B52Q37569631-005417BE-D518-4361-9ACE-7106730B6E77Q43607645-406329E5-C67C-4A3A-A198-71C19923AA85Q45196709-BA321849-DF26-4178-A413-7DE63F08A70DQ45876911-7D585B35-9BF3-4557-9B48-46153B73B23EQ45883966-B847941B-CECD-4D1F-8A7A-90E3B45CF752Q46491160-A88CFC33-5745-4BDA-B7E1-42BCDAE06839Q51790342-13C191A8-63D2-4A1F-BEC0-2009687F6E72
P2860
Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Prolonged reduction of high bl ...... oxide synthase gene delivery.
@en
type
label
Prolonged reduction of high bl ...... oxide synthase gene delivery.
@en
prefLabel
Prolonged reduction of high bl ...... oxide synthase gene delivery.
@en
P2093
P356
P1433
P1476
Prolonged reduction of high bl ...... oxide synthase gene delivery.
@en
P2093
P304
P356
10.1161/01.HYP.30.3.307
P407
P433
P577
1997-09-01T00:00:00Z